Execution diligence for investors, boards, and portfolio leads — mapping the control-point failures that turn demand, capital, and effort into avoidable leakage. Growth problems are not always market problems. ScAileboard reviews how the commercial system actually behaves — and which first fix would make the business easier to run and easier to back.
In many stalled companies, demand is being created — then lost through the middle. More capital into marketing can widen the leak rather than close it.
Across a portfolio, the strongest operators are not the ones with the best strategy decks. They are the ones with the fewest broken handoffs.
Quarterly metrics summarise outputs. The leak lives in the daily flow — invisible at board level, obvious at the dashboard the operations manager actually opens.
Every review is done with the CEO or founder — not around them. Scoped from a briefing conversation. Pricing on request.
"A structured view of whether a growth problem is market, model, or execution."
Who it's for
Investors, board members, or chairs who need to understand whether a growth miss is structural before deploying further capital or adding resource.
"Is the commercial system ready to absorb and convert new capital?"
Who it's for
Investors preparing for follow-on rounds, or boards assessing whether the operation can scale before committing further capital.
"Run the same standardised diagnostic across your active holdings — see which ones are leaking, and where."
Who it's for
Investors and boards managing more than one active holding who want a consistent, comparable view of execution risk across the portfolio — not a bespoke review built fresh for each company.
"Keep execution visibility current between board cycles — not just at the raise, or after the miss."
Who it's for
Boards and investors who've run the Portfolio Execution Review and want the pattern monitored going forward, rather than re-diagnosed from zero each time something looks off.
One review shows whether the pattern's there.